These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10702833)

  • 1. Delayed graft versus leukemia effect after allogeneic peripheral stem cell transplantation in a patient with chronic lymphocytic leukemia.
    Gutiérrez A; Solano C; Prósper F; Benet I; Sarsotti E; García-Conde J
    Haematologica; 2000 Mar; 85(3):330-2. PubMed ID: 10702833
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.
    Schetelig J; Thiede C; Bornhauser M; Schwerdtfeger R; Kiehl M; Beyer J; Sayer HG; Kroger N; Hensel M; Scheffold C; Held TK; Hoffken K; Ho AD; Kienast J; Neubauer A; Zander AR; Fauser AA; Ehninger G; Siegert W;
    J Clin Oncol; 2003 Jul; 21(14):2747-53. PubMed ID: 12860954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia.
    Pavletic ZS; Arrowsmith ER; Bierman PJ; Goodman SA; Vose JM; Tarantolo SR; Stein RS; Bociek G; Greer JP; Wu CD; Kollath JP; Weisenburger DD; Kessinger A; Wolff SN; Armitage JO; Bishop MR
    Bone Marrow Transplant; 2000 Apr; 25(7):717-22. PubMed ID: 10745256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
    Rondón G; Giralt S; Huh Y; Khouri I; Andersson B; Andreeff M; Champlin R
    Bone Marrow Transplant; 1996 Sep; 18(3):669-72. PubMed ID: 8879640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning in primary refractory prolymphocytic leukemia: graft-versus-leukemia effect without graft-versus-host disease.
    Castagna L; Nozza A; Bertuzzi A; Siracusano L; Timofeeva I; Santoro A
    Bone Marrow Transplant; 2001 Dec; 28(12):1155-6. PubMed ID: 11803359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic cell transplantation for chronic lymphocytic leukemia: an evolving concept.
    Kharfan-Dabaja MA; Anasetti C; Santos ES
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):373-85. PubMed ID: 17382245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of hematopoietic stem cell transplantation in Chronic Lymphocytic Leukemia.
    Banerji V; Johnston JB; Seftel MD
    Transfus Apher Sci; 2007 Aug; 37(1):57-62. PubMed ID: 17919979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of improved progression-free survival after nonmyeloablative allogeneic stem cell transplantation for advanced chronic lymphocytic leukemia.
    Brown JR; Kim HT; Li S; Stephans K; Fisher DC; Cutler C; Ho V; Lee SJ; Milford EL; Ritz J; Antin JH; Soiffer RJ; Gribben JG; Alyea EP
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1056-64. PubMed ID: 17084369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia.
    Doney KC; Chauncey T; Appelbaum FR;
    Bone Marrow Transplant; 2002 May; 29(10):817-23. PubMed ID: 12058231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT.
    Dreger P; Glass B; Seyfarth B; Humpe A; Claviez A; von Neuhoff N; Suttorp M; Schoch R; Schmitz N
    Bone Marrow Transplant; 2000 Dec; 26(12):1361-2. PubMed ID: 11223980
    [No Abstract]   [Full Text] [Related]  

  • 12. Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation.
    Wu BY; Guo KY; Song CY; Yang ; Li D
    Bone Marrow Transplant; 2000 Sep; 26(6):691-3. PubMed ID: 11035376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease.
    Toze CL; Galal A; Barnett MJ; Shepherd JD; Conneally EA; Hogge DE; Nantel SH; Nevill TJ; Sutherland HJ; Connors JM; Voss NJ; Kiss TL; Messner HA; Lavoie JC; Forrest DL; Song KW; Smith CA; Lipton J
    Bone Marrow Transplant; 2005 Nov; 36(9):825-30. PubMed ID: 16151430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia in donor cells after allogeneic hematopoietic stem cell transplant.
    Brunstein CG; Hirsch BA; Hammerschmidt D; McGlennen RC; Nguyen PL; Verfaillie CM
    Bone Marrow Transplant; 2002 Jun; 29(12):999-1003. PubMed ID: 12098070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-versus-leukemia in chronic lymphocytic leukemia.
    Ben-Bassat I; Raanani P; Gale RP
    Bone Marrow Transplant; 2007 Apr; 39(8):441-6. PubMed ID: 17322931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis.
    Schetelig J; van Biezen A; Brand R; Caballero D; Martino R; Itala M; García-Marco JA; Volin L; Schmitz N; Schwerdtfeger R; Ganser A; Onida F; Mohr B; Stilgenbauer S; Bornhäuser M; de Witte T; Dreger P
    J Clin Oncol; 2008 Nov; 26(31):5094-100. PubMed ID: 18711173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia.
    Sloand E; Childs RW; Solomon S; Greene A; Young NS; Barrett AJ
    Bone Marrow Transplant; 2003 Nov; 32(9):897-901. PubMed ID: 14561990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease.
    Colombo AA; Rusconi C; Esposito C; Bernasconi P; Caldera D; Lazzarino M; Alessandrino EP
    Transplantation; 2006 Apr; 81(8):1087-92. PubMed ID: 16641591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of allogeneic transplantation in low-grade lymphoma and chronic lymphocytic leukemia.
    Thomson KJ; Mackinnon S
    Curr Opin Hematol; 2006 Jul; 13(4):273-9. PubMed ID: 16755225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas.
    Bishop MR; Hou JW; Wilson WH; Steinberg SM; Odom J; Castro K; Kasten-Sportes C; Gea-Banacloche J; Marchigiani D; Gress R; Fowler DH
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):162-9. PubMed ID: 12652466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.